HPLC-fluorescence Determination of Glibenclamide in Human Plasma

XIA Chun-hua,XIONG Yu-qing,KUANG Xiao-dong,LI Yan-yan
2005-01-01
Abstract:Objective:To develop an HPLC-fluorescence method for the study of pharmacokinetics and bioavail- ability of glibenclamide in male volunteers.Method:1.5 mL plasma sample spiked with diazepam(internal stand- ard)were applied to C_(18) cartridges.After washing with water(include 20% methanol),the cartridge was eluted with methanol.The eluate was evaporated to dryness at 60℃.The residue was dissolved in methanol and injected to a Diamonsil ODS C_(18) column(4.6 mm×150 mm,5μm).The mobile phase was 0.01 mol·L~(-1) KH_2 PO_4 solution (pH=6.1 ,adjusted with H_3 PO_4)-acetonitrile(43:57).The flow rate was 1.0 mL·min~(-1).A fluorescence detec- tor was set at 235 nm excitation wavelength and 354 nm emission wavelength to monitor eluted components.A single oral dose of 2.5 mg of test tablets or reference tablets was given to each 18 volunteers in an open randomized two- way crossover design.Result:The linear range was 2-128 ng·mL~(-1),r=0.9991.The limit of determination was 2 ng·mL~(-1).The method recovery was 97.6%-98.5%.Within-day precision(RSD)and between-day precision (RSD)were less than 10%.The main pharmacokinetic parameters obtained showed no statistically significant differ- ence between two preparations.Conclusion:The method is sensitive,specific and reproducible for the determination of glibenclamide concentration in human plasma.Two products was bioequivalent.
What problem does this paper attempt to address?